A sensitive spectrophotometric method for the determination of H₂-receptor antagonists by means of N-bromosuccinimide and p-aminophenol

N. D. Yeomans, Management of peptic ulcer disease not related to Helicobacter, J. Gastroenterol. Hepatol.17 (2002) 488-494; DOI: 10.1046/j.1440-1746.2002.02726.x.10.1046/j.1440-1746.2002.02726.xSearch in Google Scholar

K. G. Kumar and L. Karpagaselvi, Determination of cimetidine in pure form and in dosage forms using N,N-dibromodimethylhydantoin, Analyst119 (1994) 1375-1376; DOI: 10.1039/AN9941901375.10.1039/an9941901375Search in Google Scholar

M. Ayad, A. Shalaby and E. J. M. Hisham, Potentiometric determination of famotidine in pharmaceutical formulations, J. Pharm. Biomed. Anal.29 (2002) 247-254; DOI: 10.1016/S0731-7085(02)00024-9.10.1016/S0731-7085(02)00024-9Search in Google Scholar

J. Novakovic, High-performance thin-layer chromatography for the determination of ranitidine hydrochloride and famotidine in pharmaceuticals, J. Chromatogr. A.846 (1999) 193-198; DOI: 10.1016/S0021-9673(99)00510-5.10.1016/S0021-9673(99)00510-5Search in Google Scholar

C. Ho, H. M. Huang, S. Y. Hsu, C. Y. Shaw and B. L. Chang, Simultaneous high-performance liquid chromatographic analysis for famotidine, ranitidine HCl, cimetidine, and nizatidine in commercial products, Drug Dev. Ind. Pharm.25 (1999) 379-385; DOI: 10.1081/DDC-100102186.10.1081/DDC-100102186Search in Google Scholar

A. Zarghi, A. Shafaati, S. M. Foroutan and A. Khoddam, Development of a rapid HPLC method for determination of famotidine in human plasma using a monolithic column, J. Pharm. Biomed. Anal.39 (2005) 677-680; DOI: 10.1016/j.jpba.2005.03.029.10.1016/j.jpba.2005.03.029Search in Google Scholar

J. W. Luo and H. H. Q. Chen, Determination of cimetidine in human plasma by use of coupled-flow injection, solid-phase extraction, and capillary zone electrophoresis, Chromatographia53 (2001) 295-300; DOI:10.1007/BF02490427.10.1007/BF02490427Search in Google Scholar

S. A. Wring, K. E. Kilpatrick, J. T. Hutchins, S. M. Witherspoon, B. Ellis, W. Jenner and C. Serabjit-Singh, Shorter development of immunoassay for drugs: application of the novel RIMMS technique enables rapid production of monoclonal antibodies to ranitidine, J. Pharm. Biomed. Anal.19 (1999) 695-707; DOI: 10.1016/S0731-7085(98)00296-9.10.1016/S0731-7085(98)00296-9Search in Google Scholar

M. M. Badair, M. A. Korany, M. A. Elsayed and O. T. Fahmy, Spectrofluorimetric determination of three pharmaceutical thiocompounds and allopurinol using mercurochrome, Spectrosc. Lett.23 (1990) 161-173; DOI: 10.1080/00387019008054044.10.1080/00387019008054044Search in Google Scholar

A. El-Bayomi, A. El-Shanawany, A. El- Sadek and A. Abd El-Sattar, Synchronous spectrofluorimetric determination of famotidine, fluconazole and ketoconazole in bulk powder and in pharmaceutical dosage forms, Spectrosc. Lett.30 (1997) 25-46; DOI: 10.1080/00387019708002587.10.1080/00387019708002587Search in Google Scholar

F. A. El-Yazbi, A. A. Gazy, H. M. Mahgoub, M. A. El-Sayed and R. M. Youssef, Spectrophotometric and titrimetric determination of nizatidine in capsules, J. Pharm. Biomed. Anal.31 (2003) 1027-1034; DOI: 10.1016/S0731-7085(02)00699-4.10.1016/S0731-7085(02)00699-4Search in Google Scholar

A. S. Amin, I. S. Ahmed, H. A. Dessouki and E. A. Gouda, Utility of oxidation-reduction reaction for the determination of ranitidine hydrochloride in pure form in dosage forms and in the presence of its oxidative degradates, Spectrochim. A Mol. Biomol. Spectrosc.59 (2003) 695-703; DOI: 10.1016/S1386-1425(02)00226-3.10.1016/S1386-1425(02)00226-3Search in Google Scholar

A. S. Amin, S. A. Shama, I. S. Ahmed and E. A. Gouda, Spectrophotometric determination of famotidine through oxidation with N-bromosuccinimide and cerric sulphate, Anal. Lett.35 (2002) 1851-1862; DOI: 10.1081/AL-120013588.10.1081/AL-120013588Search in Google Scholar

E. M. Hassan and F. Belal, Kinetic spectrophotometric determination of nizatidine and ranitidine in pharmaceutical preparations, J. Pharm. Biomed. Anal.27 (2002) 31-38; DOI: 10.1016/S0731-7085(01)00473-3.10.1016/S0731-7085(01)00473-3Search in Google Scholar

A. Z. Abu-Zuhri, R. M. Shubietah and G. M. Badah, Extractional-spectrophotometric determination of famotidine in pharmaceutical preparations, J. Pharm. Biomed. Anal.21 (1999) 459-465; DOI: 10.1016/S0731-7085(99)00139-9.10.1016/S0731-7085(99)00139-9Search in Google Scholar

M. S. Garcia, M. I. Albero, C. Sánchez-Pedreño and M. S. Abuherb, Spectrophotometric determination of cimetidine in pharmaceuticals and urine using batch and flow-injection methods, J. Pharm. Biomed. Anal.32 (2003) 1003-1010; DOI: 10.1016/S0731-7085(03)00202-4.10.1016/S0731-7085(03)00202-4Search in Google Scholar

A. E. Gendy, M. G. El-Bardicy and K. M. Loutfy, Stability indicating method for the determination of nizatidine using 3-methyl-2-benzothiazolinone hydrazone, Spectrosc. Lett.34 (2001) 221-234; DOI: 10.1081/SL-100002011.10.1081/SL-100002011Search in Google Scholar

G. Saleh, Two selective spectrophotometric methods for the determination of amoxicillin and cefadroxil, Analyst121 (1996) 641-645; DOI: 10.1039/AN9962100641.10.1039/an9962100641Search in Google Scholar

A. Krebs, B. Starczewska, H. Puzanowska-Tarasiewicz and J. Sledz, Spectrophotometric determination of olanzapine by its oxidation with N-bromosuccinimide and cerium(IV) sulfate, Anal. Sci.22 (2006) 829-833; DOI: 10.2116/analsci.22.829.10.2116/analsci.22.82916772680Search in Google Scholar

N. Rahman and S. N. Hejaz Azmi, Spectrophotometric method for the determination of verapamil hydrochloride in pharmaceutical formulations using N-bromosuccinimide as oxidant, Farmaco59 (2004) 529-536; DOI: 10.1016/j.farmac.2004.02.008.10.1016/j.farmac.2004.02.00815231428Search in Google Scholar

B. G. Gowda, J. Seetharamappa and M. B. Melwanki, Indirect spectrophotometric determinaion of propranolol hydrochloride and piroxicam in pure and pharmaceutical formulations, Anal. Sci.18 (2002) 671-674; DOI: 10.2116/analsci.18.671.10.2116/analsci.18.67112083553Search in Google Scholar

H. F. Askal, I. H. Refaat, I. A. Darwish and M. A. Marzouq, Evaluation of N-bromosuccinimide as a new analytical reagent for the spectrophotometric determination of fluoroquinolone antibiotics, Chem. Pharm. Bull. (Tokyo)55 (2007) 1551-1556; DOI: 10.1248/cpb.55.1551.10.1248/cpb.55.155117978510Search in Google Scholar

F. Feigl, Spot Tests in Organic Analysis, Elsevier, Amsterdam 1966.Search in Google Scholar

International Conference of Harmonization of Technical Requirements for Regulation of Pharmaceuticals for Human Use, ICH Harmonize Tripartite Guidance: Validation of Analytical Procedures: Text and Methodology Q2(R1), ICH, London 2005.Search in Google Scholar

British Pharmacopoeia, Vol. I, Her Majesty's Stationery Office, London 1998.Search in Google Scholar